NDC 0069-2522 – Elrexfio
Elranatamab 44 mg/1.1mL · Injection, Solution · Subcutaneous
Product NDC0069-2522
Product details
- Brand name
- Elrexfio
- Generic name
- Elranatamab-bcmm
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761345
- Marketed since
- August 15, 2023
- Listing expires
- December 31, 2027
Active ingredients
- Elranatamab 44 mg/1.1mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0069-2522-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01) | Aug 15, 2023 |